DRE’s transparent, reliable, and accelerated evidence-based analyses can inform economic and effectiveness decisions that impact product life-cycle management, as well as patients, providers, payers and regulators.  Our expert team, in collaboration with our partners, clients and key opinion leaders (KOLs), provides strategic advice on implementing the right methodology to answer your economic research questions. DRE’s expertise and complete transparency of data and methods ensures the integrity of an assessment of the value of an intervention through a Budget Impact Model or Cost-Effectiveness analysis.

  • Budget Impact Analysis: Assess the economic impact of a health care intervention in collaboration with economic modeling experts and key opinion leaders (KOLs) or via Doctor Evidence’s expert staff and collaborative partners.
  • Cost-effectiveness Analysis: Compare the relative costs and outcomes (effects) of two or more courses of action.